摘要
目的探讨头孢曲松与头孢克肟序贯治疗下呼吸道感染临床疗效及优越性。方法将126例的下呼吸道感染患者分为观察组和对照组,观察组采用头孢曲松和头孢克肟序贯治疗,对照组给予单一头孢曲松静脉滴注治疗,观察两组临床症状改善情况及治疗费用。结果观察组的有效率为88.89%,对照组的有效率为84.13%,两组疗效的差异无统计学意义(P>0.05);观察组治疗费用明显低于对照组(P<0.01)。结论头孢曲松、头孢克肟序贯治疗下呼吸道感染是一种值得推广的经济、方便、有效的治疗方法。
Objective Discuss the clinical efficacy and superiority of ceftriaxone and cefixime on the treatment of lower respiratory tract infection in the sequential therapy.Methods 126 cases of lower respiratory tract infection were divided into the observation group and the control group. The observation group is given the sequential therapy of ceftriaxone and cefixime, while the control group is given single ceftriaxone and intravenous infusion treatment. The improvement of clinical symptoms and treatment fees were observed. Results The effective rate of the observation group is 88.89%, while that of the control group is 84.13%（P〉0.05 ）. The treatment fees of the observation group is significantly lower than that of the control group（P〈0.01 ）. Conclusion Sequential therapy of ceftriaxone and cefixime on lower respiratory tract infection is one of economic, convenient and efficient treatments. It is worth to popularize.
出处
《当代医学》
2012年第36期142-143,共2页
Contemporary Medicine
关键词
下呼吸道感染
头孢曲松
头孢克肟
序贯疗法
Lower respiratory tract infection
Ceftriaxone
Cefixime
Sequential therapy
